For: | Andreolla AP, Borges AA, Bordignon J, Duarte dos Santos CN. Mayaro Virus: The State-of-the-Art for Antiviral Drug Development. Viruses 2022;14:1787. [DOI: 10.3390/v14081787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Maffei ME, Salata C, Gribaudo G. Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins. Molecules 2022;27. [PMID: 36500445 DOI: 10.3390/molecules27238353] [Reference Citation Analysis] |
2 | Del Carpio-Orantes L, Mejía-Ramos SG, Aguilar-Silva A. Seroprevalence of Mayaro virus infection in Veracruz, Mexico. Travel Med Infect Dis 2022;50:102464. [PMID: 36155819 DOI: 10.1016/j.tmaid.2022.102464] [Reference Citation Analysis] |